Search clinical trials for: Castrate-Resistant Prostate Cancer
Total 87451 results
-
Arvinas Androgen Receptor, Inc.RecruitingProstate Cancer MetastaticUnited States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
Bioray LaboratoriesChanghai HospitalSuspendedCastrate-Resistant Prostate CancerChina
-
Ionis Pharmaceuticals, Inc.CompletedCastrate-Resistant Prostate CancerUnited States, Puerto Rico, Hungary, Romania, Russian Federation, Poland
-
Zhejiang UniversityBioray LaboratoriesCompletedCastrate-Resistant Prostate CancerChina
-
PfizerTerminatedDisease ProgressionUnited States, Belgium, France, Argentina, United Kingdom
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
Hoffmann-La RocheCompleted
-
M.D. Anderson Cancer CenterTerminated
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
CelgeneCompletedProstate CancerUnited States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
M.D. Anderson Cancer CenterCompletedProstate CancerUnited States
-
AmgenCompletedCancer | Prostate Cancer | Castrate-Resistant Prostate Cancer | Mestastatic Prostate Cancer
-
European Association of Urology Research FoundationNational Cancer Institute (NCI); UMC Utrecht; Erasmus Medical Center; University... and other collaboratorsNot yet recruiting
-
Institute of Cancer Research, United KingdomRecruiting
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingMalignant Solid Neoplasm | Breast Carcinoma | Metastatic Prostate Carcinoma | Ovarian Carcinoma | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Pancreatic Exocrine Neoplasm | Stage IVB Prostate Cancer American Joint Committee on Cancer v8United States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingAdvanced Solid TumorUnited States, Germany
-
University Hospital PadovaNot yet recruiting
-
First Affiliated Hospital of Chongqing Medical...RecruitingPSMA | Prostate Cancer Stage | SPECTChina
-
University Health Network, TorontoNot yet recruitingPost-Operative Prostate Cancer
-
Lionel.D.Lewis, MDDartmouth Cancer CenterNot yet recruitingResectable Localized Prostate Cancer
-
Nazmy Edward SeifRecruitingRenal Impairment | Prostate Cancer | Surgery | Bladder Cancer | Renal Injury, AcuteEgypt
-
Maastricht University Medical CenterJessa HospitalNot yet recruiting
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingMetastatic Castration-resistant Prostate CancerSwitzerland
-
University of FloridaEDAP-TMS Focal OneNot yet recruiting
-
Fusion Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Chang Gung Memorial HospitalRecruitingProstate Cancer | Magnetic Resonance Imaging | Randomized Controlled TrialTaiwan
-
Twinpig Biolab, Inc.Not yet recruitingHepatocellular Carcinoma | Colorectal Cancer | NSCLC | Prostate Cancer
-
Apollo Therapeutics LtdNot yet recruitingColorectal Cancer | Pancreatic Adenocarcinoma | Ovarian Cancer | Prostate Cancer | Gastric Adenocarcinoma | Cholangiocarcinoma | Triple Negative Breast Cancer | Endometrial Adenocarcinoma | Appendiceal Adenocarcinoma
-
IRCCS San RaffaeleRecruiting
-
Oslo University HospitalUniversity Hospital, AkershusRecruiting
-
Complement Theory Inc.RecruitingBreast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Other CancerUnited States
-
University College, LondonUniversity College London HospitalsRecruitingProstate CancerUnited Kingdom
-
NYU Langone HealthRecruitingProstate CancerUnited States
-
Adam S. Kibel, MDNational Cancer Institute (NCI)RecruitingProstate Cancer | Polygenic Risk ScoreUnited States
-
Debiopharm International SANot yet recruiting
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
University of MiamiNot yet recruitingProstate Cancer | Prostate Adenocarcinoma | Hormone Sensitive Prostate CancerUnited States
-
Robert Bok, MD, PhDNational Cancer Institute (NCI)Not yet recruitingProstate CancerUnited States
-
Peking University First HospitalRecruiting
-
University Hospital, EssenBristol-Myers Squibb; Advanced Accelerator ApplicationsNot yet recruitingVery High Risk Prostate CarcinomaGermany
-
Norroy Bioscience Co., LTDRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Not yet recruitingProstate Cancer | Advanced Cancer
-
Peking University First HospitalNot yet recruiting
-
Mayo ClinicNot yet recruitingLocalized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruitingOligometastatic Prostate Cancer | Locally Advanced Prostate CancerChina
-
The First Affiliated Hospital of Xiamen UniversityRecruiting